PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hepatitis B virus reemerges with long-term nucleoside analog treatment

Virological breakthrough not linked to antiviral drug resistance; non-adherence to medication likely

2011-04-28
(Press-News.org) A recently published study revealed that virological breakthrough (VBT) is common in patients receiving nucleoside analogs (NUCs) for chronic hepatitis B. Nearly 40% of the VBTs found were not related to antiviral drug resistance. Details of this retrospective study are published in the May issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

VBT is the first manifestation of antiviral drug resistance during NUC therapy of chronic hepatitis B. NUC drugs approved for treatment of chronic hepatitis B include lamivudine (LAM), adefovir (ADV), entecavir (ETV), telbivudine (TBV), and tenofovir (TDF). While the medications suppress the virus with few side effects, they do not eradicate HBV and require long-term treatment to provide clinical benefit. With long-term NUC therapy, studies have shown an increasing risk of drug resistance particularly with monotherapy regimens.

In the current study, Anna Lok, M.D. and colleagues from the University of Michigan Health System examined the incidence of VBT and genotypic resistance (GR) in 148 patients with chronic hepatitis B who were treated with NUCs between January 2000 and July 2010. The mean age of study participants was 45 years and 73% were male. Researchers reviewed medical records and recorded patient demographics, hepatitis B virus (HBV) markers, liver panel, blood counts and liver histology.

Results showed that during a mean follow-up of 38 months, 39 (26%) patients had at least one VBT, and upon retesting, 15 (38%) of these patients did not have a VBT and 10 had no evidence of GR. Researchers reported the probability of VBT, confirmed VBT, and GR at five years was 46%, 30%, and 34%, respectively. "Our analysis showed an alarmingly high rate of VBT in clinical practice and the only factor significantly linked to VBT was failure to achieve undectectable HBV DNA," said Dr. Lok.

HBV DNA decreased in the ten patients who initially experienced a VBT, but who did not have confirmed VBT or GR, when the same drug regimen was maintained. Nine of these patients had undetectable HBV DNA at the most recent follow-up, a mean of 7 months after the initial VBT. These data suggest that nonadherence to medication may be a common cause of VBT. "Counseling patients with chronic hepatitis B on the importance of medication adherence, and confirming reemergence of the virus and genetic mutations that cause resistance, can help to avoid unnecessary changes to antiviral treatments," advised Dr. Lok.

INFORMATION:

Article: "Virological Breakthrough and Resistance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in Clinical Practice." Chanunta Hongthanakorn, Watcharasak Chotiyaputta, Kelly Oberhelman, Robert J. Fontana, Jorge A. Marrero, Tracy Licari and Anna S.F. Lok. Hepatology; Published Online: March 24, 2011 (DOI: 10.1002/hep.24318); Print Issue Date: May 2011. http://onlinelibrary.wiley.com/doi/10.1002/hep.24318/abstract.

This study is published in Hepatology. Media wishing to receive a PDF of the articles may contact healthnews@wiley.com.

About the Journal

Hepatology is the premier publication in the field of liver disease, publishing original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished Editorial Board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism. Hepatology is published on behalf of the American Association for the Study of Liver Diseases (AASLD). For more information, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1527-3350 .

About Wiley-Blackwell

Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.

END



ELSE PRESS RELEASES FROM THIS DATE:

2 graphene layers may be better than 1

2 graphene layers may be better than 1
2011-04-28
Researchers at the National Institute of Standards and Technology (NIST) have shown that the electronic properties of two layers of graphene vary on the nanometer scale. The surprising new results reveal that not only does the difference in the strength of the electric charges between the two layers vary across the layers, but they also actually reverse in sign to create randomly distributed puddles of alternating positive and negative charges. Reported in Nature Physics,* the new measurements bring graphene a step closer to being used in practical electronic devices. Graphene, ...

Illinois Drugged Driving Law: Unbending and Complex

2011-04-28
Illinois Drugged Driving Law: Unbending and Complex Illinois law is tough on anyone caught behind the wheel under the influence of drugs to the point that he or she cannot safely drive. And it is not a defense that the drug was legal for the individual to use. A Rising Trend? According to the federal government, the percentage of fatally injured drivers with drugs in their systems is on the rise nationally. The National Highway Transportation Safety Administration, part of the U.S. Department of Transportation, announced in November 2010 the results of an important ...

Dunwoody Hotel Near Atlanta Announces the New Perimeter Dining Card Package

Dunwoody Hotel Near Atlanta Announces the New Perimeter Dining Card Package
2011-04-28
The Holiday Inn Express & Suites Atlanta Perimeter Hotel (North) near Perimeter Mall announces the Perimeter Dining Card Package. Available for a limited time, guests who book this package will receive a $25 Perimeter Passion Dining Card (must have a minimum $50 purchase). Only one certificate can be used per table and does not include alcoholic beverages, gratuity or tax. Some restrictions and blackout dates may apply. Perimeter Passion Dining Card restaurants include: - Wildfire - McKendricks - Ruth's Chris Steak House - Nancy G's Cafe - Sage Woodfire Tavern ...

NIST prototypes framework for evaluating sustainability standards

2011-04-28
As manufacturers and other businesses step up efforts to cut waste, reduce energy use and improve the overall sustainability of their products and processes, the number of planet-friendly standards and regulations also is increasing at a rapid clip, creating a sometimes-confusing array of options for "going green." National Institute of Standards and Technology (NIST) researchers have prototyped a framework to help organizations of all types sort through the welter of choices and evaluate and implement sustainability standards most appropriate for their operations and interests. The ...

Tobacco-derived compound prevents memory loss in Alzheimer's disease mice

Tobacco-derived compound prevents memory loss in Alzheimers disease mice
2011-04-28
Tampa, FL (For immediate release) -- Cotinine, a compound derived from tobacco, reduced plaques associated with dementia and prevented memory loss in a mouse model of Alzheimer's disease, a study led by researchers at Bay Pines VA Healthcare System and the University of South Florida found. The findings are reported online in the Journal of Alzheimer's Disease in advance of print publication. "We found a compound that protects neurons, prevents the progression of Alzheimer's disease pathology, enhances memory and has been shown to be safe," said Valentina Echeverria, ...

Atlanta Orthopedic Doctor Peter Symbas Named Official Physician for Atlanta Silverbacks

Atlanta Orthopedic Doctor Peter Symbas Named Official Physician for Atlanta Silverbacks
2011-04-28
Peter Symbas, an Atlanta orthopedic doctor with Southern Orthopaedic Specialists, was recently named the Official Sports Medicine Provider and Team Physician for the Atlanta Silverbacks, an Atlanta soccer organization. Southern Orthopaedics Specialists, an official partner of the Silverbacks, is a full service Atlanta orthopedics practice specializing in orthopedic surgery and sports medicine. Dr. Symbas, an Atlanta native, has a relevant background in soccer, experience that will be valuable as his work as an Atlanta orthopedic doctor for the Silverbacks. Symbas was ...

Severity of hepatitis C and HIV co-infection in mothers contribute to HCV transmission to child

2011-04-28
New research shows that high maternal viral load and co-infection with human immunodeficiency virus (HIV) are the only risk factors associated with vertical transmission of the hepatitis C virus (HCV-VT). A variation in the infant's IL28B gene (CC) is associated independently with the spontaneous clearance of HCV genotype-1 among infected children. The status of IL28B in the mother or children did not increase risk of HCV-VT in this study. Findings are published in the May issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases. ...

Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine

2011-04-28
After the manufacturer of the Alzheimer's drug memantine submitted a supplementary analysis of study data, the German Institute for Quality and Efficiency in Health Care (IQWiG) sees proof of a benefit of the drug for cognitive function, as well as indications of a benefit for activities of daily living, at least for a treatment period of 6 months. This changes the conclusions of the first IQWiG benefit assessment of 2009. IQWiG had repeatedly called upon the manufacturer Merz to provide a renewed analysis of study data appropriate to the research question. Additional ...

Andromeda's coat of many colors

2011-04-28
VIDEO: ESA's fleet of space telescopes has captured the nearby Andromeda Galaxy, also known as M31, in different wavelengths. Most of these wavelengths are invisible to the eye and each shows... Click here for more information. ESA's fleet of space telescopes has captured the nearby Andromeda Galaxy, also known as M31, in different wavelengths. Most of these wavelengths are invisible to the eye and each shows a different aspect of the galaxy's nature. Visible light, as seen ...

Atlanta Pool Service Company Piranha Pool Management Highlights Key Steps For Summer Pool Preparation

Atlanta Pool Service Company Piranha Pool Management Highlights Key Steps For Summer Pool Preparation
2011-04-28
Atlanta pool service company Piranha Pool Management is recommending that homeowners in the Atlanta area properly prepare their pools for renewed use in the coming months. After going unused with minimal maintenance in the winter, pool preparation is essential before summertime. Piranha Pool Management provides comprehensive Atlanta pool maintenance and repair, including a summer start-up service. In temperate cities like Atlanta, pools are strongly affected by the change in seasons. In the fall, they are covered to keep out the falling leaves and dropping temperatures, ...

LAST 30 PRESS RELEASES:

Science reveals why you can’t resist a snack – even when you’re full

Kidney cancer study finds belzutifan plus pembrolizumab post-surgery helps patients at high risk for relapse stay cancer-free longer

Alkali cation effects in electrochemical carbon dioxide reduction

Test platforms for charging wireless cars now fit on a bench

$3 million NIH grant funds national study of Medicare Advantage’s benefit expansion into social supports

Amplified Sciences achieves CAP accreditation for cutting-edge diagnostic lab

Fred Hutch announces 12 recipients of the annual Harold M. Weintraub Graduate Student Award

Native forest litter helps rebuild soil life in post-mining landscapes

Mountain soils in arid regions may emit more greenhouse gas as climate shifts, new study finds

Pairing biochar with other soil amendments could unlock stronger gains in soil health

Why do we get a skip in our step when we’re happy? Thank dopamine

UC Irvine scientists uncover cellular mechanism behind muscle repair

Platform to map living brain noninvasively takes next big step

Stress-testing the Cascadia Subduction Zone reveals variability that could impact how earthquakes spread

We may be underestimating the true carbon cost of northern wildfires

Blood test predicts which bladder cancer patients may safely skip surgery

Kennesaw State's Vijay Anand honored as National Academy of Inventors Senior Member

Recovery from whaling reveals the role of age in Humpback reproduction 

Can the canny tick help prevent disease like MS and cancer?

Newcomer children show lower rates of emergency department use for non‑urgent conditions, study finds

Cognitive and neuropsychiatric function in former American football players

From trash to climate tech: rubber gloves find new life as carbon capturers materials

A step towards needed treatments for hantaviruses in new molecular map

Boys are more motivated, while girls are more compassionate?

Study identifies opposing roles for IL6 and IL6R in long-term mortality

AI accurately spots medical disorder from privacy-conscious hand images

Transient Pauli blocking for broadband ultrafast optical switching

Political polarization can spur CO2 emissions, stymie climate action

Researchers develop new strategy for improving inverted perovskite solar cells

Yes! The role of YAP and CTGF as potential therapeutic targets for preventing severe liver disease

[Press-News.org] Hepatitis B virus reemerges with long-term nucleoside analog treatment
Virological breakthrough not linked to antiviral drug resistance; non-adherence to medication likely